Robert Incoom
The researcher has conducted extensive work across a broad range of topics within pharmacology and public health. Their research primarily centers on the development and evaluation of strategies for improving antibiotic utilization in developing countries, addressing global challenges such as antimicrobial resistance and reducing antibiotic overuse. The researcher has examined the role of pharmaceuticals and pharmacoeconomics in mitigating these challenges, particularly focusing on the availability and economic impacts of biosimilars across African, Asian, European, and South American nations. Their work also highlights the importance of patient outcomes through studies of antibiotics sold without prescriptions and their impact on community pharmacies and drug outlets. Additionally, the researcher has explored the pharmacoeconomic implications of antibiotic stewardship practices, including long-acting insulin analogues and their biosimilars. Through these investigations, the researcher has provided valuable insights into the sustainable use of pharmaceuticals for public health purposes.
Antibiotic Use and Resistance
Biosimilars and Bioanalytical Methods
Pharmaceutical Economics and Policy
Pharmaceutical Practices and Patient Outcomes
Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries
Open AccessResponse to: ‘letter to the editor: “A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials “’
Open AccessAntimicrobial stewardship capacity and antibiotic utilisation practices in the Cape Coast Teaching Hospital, Ghana: A point prevalence survey study
Open AccessSelling antibiotics without prescriptions among community pharmacies and drug outlets: a simulated client study from Ghana
Selling antibiotics without prescriptions among community pharmacies and drug outlets: a simulated client study from Ghana
Open AccessUtilising cumulative antibiogram data to enhance antibiotic stewardship capacity in the Cape Coast Teaching Hospital, Ghana
Open AccessTackling antimicrobial resistance across sub-Saharan Africa: current challenges and implications for the future
Open AccessAdditional file 1 of Utilising cumulative antibiogram data to enhance antibiotic stewardship capacity in the Cape Coast Teaching Hospital, Ghana
Open AccessAdditional file 4 of Utilising cumulative antibiogram data to enhance antibiotic stewardship capacity in the Cape Coast Teaching Hospital, Ghana
Open AccessAdditional file 6 of Utilising cumulative antibiogram data to enhance antibiotic stewardship capacity in the Cape Coast Teaching Hospital, Ghana
Open AccessAdditional file 2 of Utilising cumulative antibiogram data to enhance antibiotic stewardship capacity in the Cape Coast Teaching Hospital, Ghana
Open AccessAdditional file 5 of Utilising cumulative antibiogram data to enhance antibiotic stewardship capacity in the Cape Coast Teaching Hospital, Ghana
Open AccessAdditional file 3 of Utilising cumulative antibiogram data to enhance antibiotic stewardship capacity in the Cape Coast Teaching Hospital, Ghana
Open AccessChallenges and Innovations Brought about by the COVID-19 Pandemic Regarding Medical and Pharmacy Education Especially in Africa and Implications for the Future
Open AccessAvailability and use of long-acting insulin analogues including their biosimilars across Africa; findings and implications
Availability and Use of Long-Acting Insulin Analogues Including Their Biosimilars across Africa: Findings and Implications
Open AccessThe Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future
Open AccessStrategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries
Open AccessDepartment of Pharmacy Practice
Kwame Nkrumah University of Science and Technology